Brief: Kainos Medicine Grants Jiangsu Aidea Exclusive License For Anti-HIV Medicine
20/04/2023 10:22
April 20 (Reuters) - Jiangsu Aidea Pharmaceutical Co Ltd
688488.SS :
* SAYS SOUTH KOREA'S KAINOS MEDICINE INC GRANTS CO EXCLUSIVE
LICENSE FOR RESEARCH AND DEVELOPMENT, SALES OF ANTI-HIV MEDICINE
IN OVERSEAS MARKETS EXCLUDING SOUTH KOREA, MAINLAND CHINA, HONG
KONG AND TAIWAN
Source text
Further company coverage: 688488.SS
(Reporting by Hong Kong newsroom)
((Ella.Cao@thomsonreuters.com;))